Last reviewed · How we verify

NCT04402437

QL vs LP Blocks for Analgesia Following THA

Completed NA Last updated 2 August 2022
What this trial tests

NA trial testing LP Block in Surgery in 111 participants. Completed in 4 June 2021.

Timeline
23 July 2020
Primary endpoint
4 June 2021
4 June 2021

Quick facts

Lead sponsorMedical University of South Carolina
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment111
Start date23 July 2020
Primary completion4 June 2021
Estimated completion4 June 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Medical University of South Carolina

Who can join

18 and older, any sex, with Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose: Evaluate difference in postoperative opioid consumption when subjects receive a quadratus lumborum (QL) or lumbar plexus (LP) block preoperatively for total hip arthroplasty (THA). Hypothesis: Preoperative QL and LP blocks will result in similar postoperative opioid consumption following hip arthroplasty.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of lateral quadratus lumborum and lumbar plexus blocks for postoperative analgesia following total hip arthroplasty: a randomized clinical trial.
    Kelly T, Wolla CD, Wolf BJ, Hay E, et al · · 2022 · cited 15× · PMID 35688515 · DOI 10.1136/rapm-2022-103598

Verify or expand the search:

Other recruiting trials for Surgery

Currently open trials in the same condition.

Other Medical University of South Carolina trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04402437.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing